From: Two predictive precision medicine tools for hepatocellular carcinoma
Univariate analyses | Coefficient | Multivariate analyses | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | ||
N4BP3 (high vs. low) | 2.135 | 1.492–3.054 | 0.001 | 1.012 | 2.751 | 1.883–4.019 | 0.001 |
COL15A1 (high vs. low) | 0. 38 | 0.378–0.765 | 0.001 | − 0.652 | 0.521 | 0.358–0.760 | 0.001 |
ADRA2B (high vs. low) | 0.471 | 0.330–0.671 | 0.001 | − 0.537 | 0.585 | 0.399–0.856 | 0.006 |
NDST3 (high vs. low) | 0.575 | 0.404–0.818 | 0.002 | − 0.414 | 0.661 | 0.460–0.949 | 0.025 |
E2F8 (high vs. low) | 2.033 | 1.425–2.898 | 0.001 | 0.635 | 1.888 | 1.295–2.752 | 0.001 |
MAPT (high vs. low) | 1.875 | 1.315–2.672 | 0.001 | 0.462 | 1.587 | 1.101–2.288 | 0.013 |
PZP (high vs. low) | 0.597 | 0.420–0.849 | 0.004 | − 0.464 | 0.629 | 0.440–0.898 | 0.011 |
HOXD9 (high vs. low) | 1.842 | 1.294–2.623 | 0.001 | 0.374 | 1.453 | 1.011–2.089 | 0.044 |